ArticlePloS one2017

Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.

Soon-Youn Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.